Capital Investment Advisory Services’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.2M | Sell |
8,846
-1,441
| -14% | -$493K | 0.2% | 121 |
|
|
2026
Q1 | $3.62M | Sell |
10,287
-76
| -0.7% | -$27.1K | 0.26% | 90 |
|
|
2025
Q4 | $3.39M | Buy |
10,363
+117
| +1% | +$37.1K | 0.24% | 97 |
|
|
2025
Q3 | $2.89M | Sell |
10,246
-362
| -3% | -$105K | 0.23% | 107 |
|
|
2025
Q2 | $2.96M | Buy |
10,608
+93
| +0.9% | +$26.3K | 0.24% | 97 |
|
|
2025
Q1 | $3.28M | Buy |
10,515
+489
| +5% | +$144K | 0.29% | 84 |
|
|
2024
Q4 | $2.61M | Buy |
10,026
+157
| +2% | +$46.6K | 0.25% | 87 |
|
|
2024
Q3 | $3.18M | Sell |
9,869
-1,236
| -11% | -$404K | 0.3% | 79 |
|
|
2024
Q2 | $3.47M | Buy |
11,105
+418
| +4% | +$123K | 0.36% | 68 |
|
|
2024
Q1 | $3.04M | Sell |
10,687
-1,201
| -10% | -$351K | 0.33% | 75 |
|
|
2023
Q4 | $3.42M | Sell |
11,888
-146
| -1% | -$39.8K | 0.32% | 59 |
|
|
2023
Q3 | $3.23M | Sell |
12,034
-8
| -0.1% | -$2K | 0.32% | 59 |
|
|
2023
Q2 | $2.67M | Buy |
12,042
+1,950
| +19% | +$452K | 0.26% | 67 |
|
|
2023
Q1 | $2.44M | Buy |
10,092
+75
| +0.7% | +$18.4K | 0.29% | 71 |
|
|
2022
Q4 | $2.63M | Buy |
10,017
+1,097
| +12% | +$294K | 0.31% | 69 |
|
|
2022
Q3 | $2.01M | Sell |
8,920
-41
| -0.5% | -$9.94K | 0.26% | 76 |
|
|
2022
Q2 | $2.18M | Sell |
8,961
-151
| -2% | -$37K | 0.26% | 76 |
|
|
2022
Q1 | $2.2M | Sell |
9,112
-26
| -0.3% | -$5.97K | 0.24% | 86 |
|
|
2021
Q4 | $2.06M | Buy |
9,138
+489
| +6% | +$103K | 0.24% | 90 |
|
|
2021
Q3 | $1.84M | Buy |
8,649
+118
| +1% | +$27.2K | 0.23% | 92 |
|
|
2021
Q2 | $2.08M | Sell |
8,531
-51
| -0.6% | -$12.5K | 0.26% | 82 |
|
|
2021
Q1 | $2.14M | Sell |
8,582
-178
| -2% | -$42.5K | 0.3% | 79 |
|
|
2020
Q4 | $2.01M | Buy |
8,760
+1,345
| +18% | +$310K | 0.3% | 77 |
|
|
2020
Q3 | $1.89M | Buy |
7,415
+424
| +6% | +$105K | 0.35% | 68 |
|
|
2020
Q2 | $1.65M | Buy |
6,991
+26
| +0.4% | +$5.93K | 0.33% | 74 |
|
|
2020
Q1 | $1.41M | Sell |
6,965
-438
| -6% | -$95.7K | 0.34% | 65 |
|
|
2019
Q4 | $1.78M | Sell |
7,403
-56
| -0.8% | -$12.3K | 0.48% | 44 |
|
|
2019
Q3 | $1.44M | Buy |
7,459
+830
| +13% | +$159K | 0.4% | 53 |
|
|
2019
Q2 | $1.17M | Buy |
6,629
+239
| +4% | +$42.8K | 0.35% | 55 |
|
|
2019
Q1 | $1.21M | Sell |
6,390
-389
| -6% | -$74.3K | 0.45% | 41 |
|
|
2018
Q4 | $1.32M | Sell |
6,779
-74
| -1% | -$14.4K | 0.56% | 37 |
|
|
2018
Q3 | $1.42M | Sell |
6,853
-167
| -2% | -$32.9K | 0.67% | 37 |
|
|
2018
Q2 | $1.3M | Sell |
7,020
-81
| -1% | -$14.3K | 0.65% | 35 |
|
|
2018
Q1 | $1.21M | Buy |
7,101
+62
| +0.9% | +$11.4K | 0.68% | 32 |
|
|
2017
Q4 | $1.22M | Buy |
7,039
+85
| +1% | +$15K | 0.72% | 30 |
|
|
2017
Q3 | $1.3M | Buy |
6,954
+30
| +0.4% | +$5.32K | 0.8% | 30 |
|
|
2017
Q2 | $1.19M | Sell |
6,924
-292
| -4% | -$47.5K | 0.79% | 31 |
|
|
2017
Q1 | $1.18M | Buy |
7,216
+10
| +0.1% | +$1.66K | 0.87% | 26 |
|
|
2016
Q4 | $1.05M | Buy |
+7,206
| New | +$1.08M | 0.91% | 25 |
|
Other funds holding AMGN
FFM
SP
Capital Investment Advisory Services's AMGN Position: Q2 2026 in Review
Capital Investment Advisory Services reduced its Amgen (AMGN) stake by 14% in Q2 2026, selling an estimated $493K and leaving 8,846 shares worth $3.2M. The position accounts for 0.2% of the portfolio, ranked #121.
Capital Investment Advisory Services first reported a position in AMGN in Q4 2016 and has held it in 39 quarters since. The position peaked at $3.62M in Q1 2026. 1,324 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Capital Investment Advisory Services held 8,846 shares of Amgen worth $3.2M as of Q2 2026.
- Capital Investment Advisory Services sold 1,441 Amgen shares in Q2 2026, an estimated $493K.
- Amgen made up 0.2% of Capital Investment Advisory Services's portfolio in Q2 2026, its #121 holding.
- Capital Investment Advisory Services first reported a position in Amgen in Q4 2016 and has held it in 39 quarters since.
- Capital Investment Advisory Services's Amgen position peaked at $3.62M in Q1 2026.
- 1,324 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Capital Investment Advisory Services's 13F filing for Q2 2026, filed 23 Jul 2026.